Viewing Study NCT00212069


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-04-10 @ 9:16 PM
Study NCT ID: NCT00212069
Status: COMPLETED
Last Update Posted: 2013-12-11
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
Sponsor: National University Hospital, Singapore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None serum proteomics View
None gemcitabine View
None carboplatin View
None chemotherapy sensitivity View